Research progress on the correlation between periodontitis and digestive system diseases

doi:10.3877/cma.j.issn.1674-1366.2021.05.001

Abstract

Abstract:

Periodontitis is one of the most common oral diseases in the world. It is a chronic inflammatory disease of periodontal supporting tissue caused by periodontal pathogen. In recent years, studies have shown that periodontitis is related to a variety of systemic diseases, among which the relationship between periodontitis and digestive system diseases is the latest research hotspot. This article reviews the clinical and pathological correlation between periodontitis and some digestive diseases from three aspects: common intestinal diseases, liver diseases and pancreatic diseases. In addition, recommendations for future research are also provided.

Key words: Periodontitis, Intestinal diseases, Liver diseases, Pancreatic diseases

Huiqiong Zou, Yafang Liu, Han Zhang, Jiamin Zhou, Junying Yang. Research progress on the correlation between periodontitis and digestive system diseases[J]. Chinese Journal of Stomatological Research(Electronic Edition), 2021, 15(05): 261-266.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhkqyxyjzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-1366.2021.05.001

https://zhkqyxyjzz.cma-cmc.com.cn/EN/Y2021/V15/I05/261

References 49

[1]	Lu HX, Tao DY, Lo ECM，et al. The 4th national oral health survey in the mainland of China：Bckground and methodology[J]. Chin J Dent Res，2018，21（3）：161-165. DOI：10.3290/j.cjdr.a41079.
[2]	Mendonça DD, Furtado MV, Sarmento RA，et al. Periodontitis and tooth loss have negative impact on dietary intake：A cross-sectional study with stable coronary artery disease patients[J]. J Periodontol，2019，90（10）：1096-1105. DOI：10.1002/JPER.19-0036.
[3]	Bahammam MA, Attia MS. Effects of systemic simvastatin on the concentrations of visfatin，tumor necrosis factor-α，and interleukin-6 in gingival crevicular fluid in patients with type 2 diabetes and chronic periodontitis[J]. J Immunol Res，2018，2018：8481735. DOI：10.1155/2018/8481735.
[4]	Zhang L, Gao X, Zhou J，et al. Increased risks of dental caries and periodontal disease in Chinese patients with inflammatory bowel disease[J]. Int Dent J，2020，70（3）：227-236. DOI：10.1111/idj.12542.
[5]	She YY, Kong XB, Ge YP，et al. Periodontitis and inflammatory bowel disease：A meta-analysis[J]. BMC Oral Health，2020，20（1）：67. DOI：10.1186/s12903-020-1053-5.
[6]	Lin CY, Tseng KS, Liu JM，et al. Increased risk of ulcerative colitis in patients with periodontal disease：A nationwide population-based cohort study[J]. Int J Environ Res Public Health，2018，15（11）：2602. DOI：10.3390/ijerph15112602.
[7]	Kitamoto S, Nagao-Kitamoto H, Jiao Y，et al. The intermucosal connection between the mouth and gut in commensal pathobiont-driven colitis[J]. Cell，2020，182（2）：447-462. DOI：10.1016/j.cell.2020.05.048.
[8]	Strauss J, Kaplan GG, Beck PL，et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host[J]. Inflamm Bowel Dis，2011，17（9）：1971-1978. DOI：10.1002/ibd.21606.
[9]	Dharmani P, Strauss J, Ambrose C，et al. Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha[J]. Infect Immun，2011，79（7）：2597-2607. DOI：10.1128/IAI.05118-11.
[10]	Freudenheim JL, Genco RJ, LaMonte MJ，et al. Periodontal disease and breast cancer：Prospective cohort study of postmenopausal women[J]. Cancer Epidemiol Biomarkers Prev，2016，25（1）：43-50. DOI：10.1158/1055-9965.EPI-15-0750.
[11]	Michaud DS, Lu J, Peacock-Villada AY，et al. Periodontal disease assessed using clinical dental measurements and cancer risk in the ARIC study[J]. J Natl Cancer Inst，2018，110（8）：843-854. DOI：10.1093/jnci/djx278.
[12]	Bray F, Ferlay J, Soerjomataram I，et al. Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin，2018，68（6）：394-424. DOI：10.3322/caac.21492.
[13]	Arora M, Weuve J, Fall K，et al. An exploration of shared genetic risk factors between periodontal disease and cancers：A prospective co-twin study[J]. Am J Epidemiol，2010，171（2）：253-259. DOI：10.1093/aje/kwp340.
[14]	Momen-Heravi F, Babic A, Tworoger SS，et al. Periodontal disease，tooth loss and colorectal cancer risk：Results from the Nurses′ Health Study[J]. Int J Cancer，2017，140（3）：646-652. DOI：10.1002/ijc.30486.
[15]	Hwang IM, Sun LM, Lin CL，et al. Periodontal disease with treatment reduces subsequent cancer risks[J]. QJM，2014，107（10）：805-812. DOI：10.1093/qjmed/hcu078.
[16]	Li W, Xu J, Zhang R，et al. Is periodontal disease a risk indicator for colorectal cancer？A systematic review and meta-analysis[J]. J Clin Periodontol，2021，48（3）：336-347. DOI：10.1111/jcpe.13402.
[17]	Kostic AD, Chun E, Robertson L，et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment[J]. Cell Host Microbe，2013，14（2）：207-215. DOI：10.1016/j.chom.2013.07.007.
[18]	Castellarin M, Warren RL, Freeman JD，et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma[J]. Genome Res，2012，22（2）：299-306. DOI：10.1101/gr.126516.111.
[19]	Yang Y, Weng W, Peng J，et al. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-κB，and Up-regulating epression of MicroRNA-21[J]. Gastroenterology，2017，152（4）：851-866. DOI：10.1053/j.gastro.2016.11.018.
[20]	Furuta M, Ekuni D, Yamamoto T，et al. Relationship between periodontitis and hepatic abnormalities in young adults[J]. Acta Odontol Scand，2010，68（1）：27-33. DOI：10.3109/00016350903291913.
[21]	Grønkjær LL, Holmstrup P, Schou S，et al. Periodontitis in patients with cirrhosis：A cross-sectional study[J]. BMC Oral Health，2018，18（1）：22. DOI：10.1186/s12903-018-0487-5.
[22]	Tamaki N, Takaki A, Tomofuji T，et al. Stage of hepatocellular carcinoma is associated with periodontitis[J]. J Clin Periodontol，2011，38（11）：1015-1020. DOI：10.1111/j.1600-051X.2011.01777.x.
[23]	Tomofuji T, Ekuni D, Irie K，et al. Relationships between periodontal inflammation，lipid peroxide and oxidative damage of multiple organs in rats[J]. Biomed Res，2011，32（5）：343-349. DOI：10.2220/biomedres.32.343.
[24]	Dai J, Ma Y, Shi M，et al. Initial changes in alveolar bone volume for sham-operated and ovariectomized rats in ligature-induced experimental periodontitis[J]. Clin Oral Investig，2016，20（3）：581-588. DOI：10.1007/s00784-015-1531-3.
[25]	Younossi ZM, Koenig AB, Abdelatif D，et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence，incidence，and outcomes[J]. Hepatology，2016，64（1）：73-84. DOI：10.1002/hep.28431.
[26]	Kuroe K, Furuta M, Takeuchi K，et al. Association between periodontitis and fibrotic progression of non-alcoholic fatty liver among Japanese adults[J]. J Clin Periodontol，2021，48（3）：368-377. DOI：10.1111/jcpe.13415.
[27]	Yoneda M, Naka S, Nakano K，et al. Involvement of a periodontal pathogen，Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease[J]. BMC Gastroenterol，2012，12：16. DOI：10.1186/1471-230X-12-16.
[28]	Lambert A, Schwarz L, Borbath I，et al. An update on treatment options for pancreatic adenocarcinoma[J]. Ther Adv Med Oncol，2019，11：1758835919875568. DOI：10.1177/1758835919875568.
[29]	Maisonneuve P, Amar S, Lowenfels AB. Periodontal disease，edentulism，and pancreatic cancer：A meta-analysis[J]. Ann Oncol，2017，28（5）：985-995. DOI：10.1093/annonc/mdx019.
[30]	Chang JS, Tsai CR, Chen LT，et al. Investigating the association between periodontal disease and risk of pancreatic cancer[J]. Pancreas，2016，45（1）：134-141. DOI：10.1097/mpa.0000000000000419.
[31]	Huang J, Roosaar A, Axéll T，et al. A prospective cohort study on poor oral hygiene and pancreatic cancer risk[J]. Int J Cancer，2016，138（2）：340-347. DOI：10.1002/ijc.29710.
[32]	Torres PJ, Fletcher EM, Gibbons SM，et al. Characterization of the salivary microbiome in patients with pancreatic cancer[J]. Peer J，2015，3：e1373. DOI：10.7717/peerj.1373.
[33]	Gnanasekaran J, Binder Gallimidi A, Saba E，et al. Intracellular Porphyromonas gingivalis promotes the tumorigenic behavior of pancreatic carcinoma cells[J]. Cancers（Basel），2020，12（8）：2331. DOI：10.3390/cancers12082331.
[34]	Komiya Y, Shimomura Y, Higurashi T，et al. Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity[J]. Gut，2019，68（7）：1335-1337. DOI：10.1136/gutjnl-2018-316661.
[35]	Furusho H, Miyauchi M, Hyogo H，et al. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice[J]. J Gastroenterol，2013，48（11）：1259-1270. DOI：10.1007/s00535-012-0738-1.
[36]	Waghmare AS, Vhanmane PB, Savitha B，et al. Bacteremia following scaling and root planing：A clinico-microbiological study[J]. J Indian Soc Periodontol，2013，17（6）：725-730. DOI：10.4103/0972-124X.124480.
[37]	Fardini Y, Wang X, Témoin S，et al. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity[J]. Mol Microbiol，2011，82（6）：1468-1480. DOI：10.1111/j.1365-2958.2011.07905.x.
[38]	Dejea CM, Sears CL. Do biofilms confer a pro-carcinogenic state？[J]. Gut Microbes，2016，7（1）：54-57. DOI：10.1080/19490976.2015.1121363.
[39]	Abed J, Emgård JE, Zamir G，et al. Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc[J]. Cell Host Microbe，2016，20（2）：215-225. DOI：10.1016/j.chom.2016.07.006.
[40]	Inaba H, Sugita H, Kuboniwa M，et al. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation[J]. Cell Microbiol，2014，16（1）：131-145. DOI：10.1111/cmi.12211.
[41]	Lourenςo TGB, Spencer SJ, Alm EJ，et al. Defining the gut microbiota in individuals with periodontal diseases：An exploratory study[J]. J Oral Microbiol，2018，10（1）：1487741. DOI：10.1080/20002297.2018.1487741.
[42]	Nakajima M, Arimatsu K, Kato T，et al. Oral administration of P.gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver[J]. PLoS One，2015，10（7）：e0134234. DOI：10.1371/journal.pone.0134234.
[43]	Gevers D, Kugathasan S, Denson LA，et al. The treatment-naive microbiome in new-onset Crohn′s disease[J]. Cell Host Microbe，2014，15（3）：382-392. DOI：10.1016/j.chom.2014.02.005.
[44]	Pittayanon R, Lau JT, Yuan Y，et al. Gut microbiota in patients with irritable bowel syndrome：A systematic review[J]. Gastroenterology，2019，157（1）：97-108. DOI：10.1053/j.gastro.2019.03.049.
[45]	Sánchez-Zauco N, Torres J, Gómez A，et al. Circulating blood levels of IL-6，IFN-γ，and IL-10 as potential diagnostic biomarkers in gastric cancer：A controlled study[J]. BMC Cancer，2017，17（1）：384. DOI：10.1186/s12885-017-3310-9.
[46]	Ding LY, Liang LZ, Zhao YX，et al. Porphyromonas gingivalis-derived lipopolysaccharide causes excessive hepatic lipid accumulation via activating NF-κB and JNK signaling pathways[J]. Oral Dis，2019，25（7）：1789-1797. DOI：10.1111/odi.13153.
[47]	Gur C, Ibrahim Y, Isaacson B，et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack[J]. Immunity，2015，42（2）：344-355. DOI：10.1016/j.immuni.2015.01.010.
[48]	Hajishengallis G. Periodontitis：From microbial immune subversion to systemic inflammation[J]. Nat Rev Immunol，2015，15（1）：30-44. DOI：10.1038/nri3785.
[49]	Nesse W, Abbas F, van der Ploeg I，et al. Periodontal inflamed surface area：Quantifying inflammatory burden[J]. J Clin Periodontol，2008，35（8）：668-673. DOI：10.1111/j.1600-051X.2008.01249.x.

Please choose a citation manager

Content to export